Alyglo® (immune globulin intravenous, human-stwk)
for Primary Immunodeficiency Disorder

Alyglo (immune globulin intravenous, human-stwk) is an intravenous immune globulin therapy used to treat primary humoral immunodeficiency (PI) in adults. It boosts the immune system to reduce infections, sick days, and hospitalizations. Alyglo contains a broad spectrum of IgG antibodies to bacterial and viral pathogens and their toxins. Made from pooled human plasma, it undergoes virus risk-reduction processes and removes coagulation factor XIa to lower the risk of thromboembolic events.

Heart